- Bind to FXR as CRC inhibitor- Promote cancer initiation by upregulating IL-8, ERK1/2, and inhibiting STAT3 phosphorylation- Activate MAPK pathway via upregulation of uPAR and calcium signaling. Here, MAPK3 is linked to cancer.